Moberg Pharma AB (publ) (STO:MOB)
9.43
-0.07 (-0.74%)
Jan 21, 2026, 12:35 PM CET
Moberg Pharma AB Revenue
Moberg Pharma AB had revenue of 4.01M SEK in the quarter ending September 30, 2025, with 3.89% growth. This brings the company's revenue in the last twelve months to 12.50M, up 42.27% year-over-year. In the year 2024, Moberg Pharma AB had annual revenue of 9.81M.
Revenue (ttm)
12.50M
Revenue Growth
+42.27%
P/S Ratio
35.73
Revenue / Employee
2.08M
Employees
10
Market Cap
446.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.81M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 207.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 33.66M | -16.83M | -33.33% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orexo AB | 543.50M |
| EQL Pharma AB | 399.07M |
| Enzymatica AB | 52.73M |
| Cinclus Pharma Holding AB | 48.42M |
| Cereno Scientific AB | 46.66M |
| Nanexa AB | 31.92M |
| Newbury Pharmaceuticals AB | 31.57M |
| Klaria Pharma Holding AB (publ.) | 10.05M |